La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Fulguration of Accessory Pathways in any Location: Report of Seventy Cases

Identifieur interne : 005202 ( Main/Exploration ); précédent : 005201; suivant : 005203

Fulguration of Accessory Pathways in any Location: Report of Seventy Cases

Auteurs : J. F. Warin [France] ; M. Haissaguerre [France]

Source :

RBID : ISTEX:86D28E8D4E841876FA3D65FE23935CFD9F50A579

English descriptors

Abstract

Ablation of accessory pathways (AP) in any location was performed in 70 consecutive patients using either a right or a left approach. Left free wall pathways were approached via a patent foramen ovale (eight patients) or by transseptal catheter (eight patients). The best ablation site was localized by recording a potential most likely due to Kent bundle activation (33/70 patients), the earliest site of retrograde atrial activation during orthodromic reciprocating tachycardia, earliest ventricular potentials recorded before or synchronous with the delta wave in standard ECG leads, disappearance of preexcitation due to pressure of the catheter on the AP (eight patients), good degree of pacemap concordance with ventricular preexcitation. Two 160 joules cathodal shocks in close succession were delivered and the sequence reeated depending on the results. Preexcitation disappeared in 63 patients and there was no recurrence of arrhythmia in 68 patients without any antiarrhythmic therapy over a follow‐up ranging from 1 to 42 months. No serious side effects were observed except for two patients who developed permanent complete AV block. However, one of them occurred after an unsuccessful surgical attempt which had damaged the AV function. Fulguration is effective for APs in diverse locations. These results indicate that appropriate treatment of patient with the Wolff‐Parkinson‐White syndrome should be reassessed. At present, the therapy of arrhythmias related to the Wolff‐Parkinson‐White syndrome is no longer a question of either antiarrhythmic drugs or surgery. Fulguration, in our experience, is effective for abolishing accessory pathways in any location.

Url:
DOI: 10.1111/j.1540-8159.1989.tb02649.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Fulguration of Accessory Pathways in any Location: Report of Seventy Cases</title>
<author>
<name sortKey="Warin, J F" sort="Warin, J F" uniqKey="Warin J" first="J. F." last="Warin">J. F. Warin</name>
</author>
<author>
<name sortKey="Haissaguerre, M" sort="Haissaguerre, M" uniqKey="Haissaguerre M" first="M." last="Haissaguerre">M. Haissaguerre</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:86D28E8D4E841876FA3D65FE23935CFD9F50A579</idno>
<date when="1989" year="1989">1989</date>
<idno type="doi">10.1111/j.1540-8159.1989.tb02649.x</idno>
<idno type="url">https://api.istex.fr/document/86D28E8D4E841876FA3D65FE23935CFD9F50A579/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000F81</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F81</idno>
<idno type="wicri:Area/Istex/Curation">000F79</idno>
<idno type="wicri:Area/Istex/Checkpoint">001F44</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001F44</idno>
<idno type="wicri:doubleKey">0147-8389:1989:Warin J:fulguration:of:accessory</idno>
<idno type="wicri:Area/Main/Merge">005D01</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:2466255</idno>
<idno type="wicri:Area/PubMed/Corpus">001857</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001857</idno>
<idno type="wicri:Area/PubMed/Curation">001816</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001816</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001816</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001816</idno>
<idno type="wicri:Area/Ncbi/Merge">001364</idno>
<idno type="wicri:Area/Ncbi/Curation">001364</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001364</idno>
<idno type="wicri:doubleKey">0147-8389:1989:Warin J:fulguration:of:accessory</idno>
<idno type="wicri:Area/Main/Merge">005C46</idno>
<idno type="wicri:Area/Main/Curation">005202</idno>
<idno type="wicri:Area/Main/Exploration">005202</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Fulguration of Accessory Pathways in any Location: Report of Seventy Cases</title>
<author>
<name sortKey="Warin, J F" sort="Warin, J F" uniqKey="Warin J" first="J. F." last="Warin">J. F. Warin</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Cardiology, Saint‐Andre Hospital, University of Bordeaux II</wicri:regionArea>
<wicri:noRegion>University of Bordeaux II</wicri:noRegion>
<wicri:noRegion>University of Bordeaux II</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr" wicri:curation="lc">France</country>
<wicri:regionArea>Address for reprints: J.F. Warin, MD, Saint‐Andre Hospital, 1 Rue Jean Burget</wicri:regionArea>
<wicri:noRegion>1 Rue Jean Burget</wicri:noRegion>
<wicri:noRegion>1 Rue Jean Burget</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Haissaguerre, M" sort="Haissaguerre, M" uniqKey="Haissaguerre M" first="M." last="Haissaguerre">M. Haissaguerre</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Cardiology, Saint‐Andre Hospital, University of Bordeaux II</wicri:regionArea>
<wicri:noRegion>University of Bordeaux II</wicri:noRegion>
<wicri:noRegion>University of Bordeaux II</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Pacing and Clinical Electrophysiology</title>
<idno type="ISSN">0147-8389</idno>
<idno type="eISSN">1540-8159</idno>
<imprint>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="1989-01">1989-01</date>
<biblScope unit="volume">12</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="215">215</biblScope>
<biblScope unit="page" to="218">218</biblScope>
</imprint>
<idno type="ISSN">0147-8389</idno>
</series>
<idno type="istex">86D28E8D4E841876FA3D65FE23935CFD9F50A579</idno>
<idno type="DOI">10.1111/j.1540-8159.1989.tb02649.x</idno>
<idno type="ArticleID">PACE215</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0147-8389</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Action Potentials</term>
<term>Adult</term>
<term>Atrial Fibrillation (physiopathology)</term>
<term>Atrial Fibrillation (surgery)</term>
<term>Electrocoagulation (adverse effects)</term>
<term>Electrocoagulation (methods)</term>
<term>Female</term>
<term>Heart Block (etiology)</term>
<term>Heart Conduction System (surgery)</term>
<term>Humans</term>
<term>Male</term>
<term>Neural Pathways (surgery)</term>
<term>Tachycardia (physiopathology)</term>
<term>Tachycardia (surgery)</term>
<term>Wolff-Parkinson-White Syndrome (physiopathology)</term>
<term>Wolff-Parkinson-White Syndrome (surgery)</term>
<term>accessory pathways</term>
<term>catheter ablation</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Electrocoagulation</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Heart Block</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Electrocoagulation</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Atrial Fibrillation</term>
<term>Tachycardia</term>
<term>Wolff-Parkinson-White Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Atrial Fibrillation</term>
<term>Heart Conduction System</term>
<term>Neural Pathways</term>
<term>Tachycardia</term>
<term>Wolff-Parkinson-White Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Action Potentials</term>
<term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Ablation of accessory pathways (AP) in any location was performed in 70 consecutive patients using either a right or a left approach. Left free wall pathways were approached via a patent foramen ovale (eight patients) or by transseptal catheter (eight patients). The best ablation site was localized by recording a potential most likely due to Kent bundle activation (33/70 patients), the earliest site of retrograde atrial activation during orthodromic reciprocating tachycardia, earliest ventricular potentials recorded before or synchronous with the delta wave in standard ECG leads, disappearance of preexcitation due to pressure of the catheter on the AP (eight patients), good degree of pacemap concordance with ventricular preexcitation. Two 160 joules cathodal shocks in close succession were delivered and the sequence reeated depending on the results. Preexcitation disappeared in 63 patients and there was no recurrence of arrhythmia in 68 patients without any antiarrhythmic therapy over a follow‐up ranging from 1 to 42 months. No serious side effects were observed except for two patients who developed permanent complete AV block. However, one of them occurred after an unsuccessful surgical attempt which had damaged the AV function. Fulguration is effective for APs in diverse locations. These results indicate that appropriate treatment of patient with the Wolff‐Parkinson‐White syndrome should be reassessed. At present, the therapy of arrhythmias related to the Wolff‐Parkinson‐White syndrome is no longer a question of either antiarrhythmic drugs or surgery. Fulguration, in our experience, is effective for abolishing accessory pathways in any location.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
</list>
<tree>
<country name="France">
<noRegion>
<name sortKey="Warin, J F" sort="Warin, J F" uniqKey="Warin J" first="J. F." last="Warin">J. F. Warin</name>
</noRegion>
<name sortKey="Haissaguerre, M" sort="Haissaguerre, M" uniqKey="Haissaguerre M" first="M." last="Haissaguerre">M. Haissaguerre</name>
<name sortKey="Warin, J F" sort="Warin, J F" uniqKey="Warin J" first="J. F." last="Warin">J. F. Warin</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005202 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005202 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:86D28E8D4E841876FA3D65FE23935CFD9F50A579
   |texte=   Fulguration of Accessory Pathways in any Location: Report of Seventy Cases
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024